| - GRCh37:
- Chr2:47639566-47639568
- GRCh38:
- Chr2:47412427-47412429
| MSH2 | | Lynch syndrome 1 | Likely pathogenic (Jun 2, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47705489-47705495
- GRCh38:
- Chr2:47478350-47478356
| MSH2 | W312fs, W465fs, W624fs, W698fs, W714fs, W744fs, W753fs, W764fs, W777fs | Lynch syndrome 1 | Likely pathogenic (Apr 4, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47655013-47657819
- GRCh38:
- Chr2:47427874-47430680
| MSH2 | | Lynch syndrome 1 | Pathogenic (Feb 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47703542-47703545
- GRCh38:
- Chr2:47476403-47476406
| MSH2 | | Lynch syndrome 1 | Likely pathogenic (Jun 12, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47657050-47657051
- GRCh38:
- Chr2:47429911-47429912
| MSH2 | N117fs, N276fs, N350fs, N366fs, N396fs, N405fs, N416fs | Lynch syndrome 1 | Pathogenic (Feb 14, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47693945-47693949
- GRCh38:
- Chr2:47466806-47466810
| MSH2 | | Lynch syndrome 1 | Likely pathogenic (Mar 16, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47637505-47637511
- GRCh38:
- Chr2:47410366-47410372
| MSH2 | | Lynch syndrome 1 | Likely pathogenic (Jul 7, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47482114-47665324
| BCYRN1, EPCAM, MSH2 | | Lynch syndrome 1 | Pathogenic (May 26, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr2:47526868-47665324
| BCYRN1, EPCAM, MSH2 | | Lynch syndrome 1 | Pathogenic (May 26, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr3:37092000-37092001
- GRCh38:
- Chr3:37050509-37050510
| MLH1 | S353*, S370*, S470*, S613*, S642*, S656*, S678*, S680*, S711* | Lynch syndrome 1 | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:37067255
- GRCh38:
- Chr3:37025764
| MLH1 | E149fs, E292fs, E32fs, E357fs, E390fs, E49fs | Lynch syndrome 1 | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:47690170-47708011
| MSH2 | | Lynch syndrome 1 | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:47702343-47702344
- GRCh38:
- Chr2:47475204-47475205
| MSH2 | I196fs, I349fs, I508fs, I582fs, I598fs, I628fs, I637fs, I648fs, I661fs | Lynch syndrome 1 | Likely pathogenic | no assertion criteria provided |
| - GRCh38:
- Chr2:47614711-47657080
| MSH2 | | Lynch syndrome 1 | Likely pathogenic | no assertion criteria provided |
| - GRCh38:
- Chr2:47612305-47643568
| MSH2 | | Lynch syndrome 1 | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:48032129-48032130
- GRCh38:
- Chr2:47804990-47804991
| MSH6 | T1000fs, T102fs, T1045fs, T1076fs, T1117fs, T1119fs, T1149fs, T1175fs, T1177fs, T1207fs, T124fs, T490fs, T653fs, T873fs, T887fs | Lynch syndrome 1 | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:48027119-48027120
- GRCh38:
- Chr2:47799980-47799981
| MSH6 | D365*, D492*, D537*, D568*, D611*, D641*, D667*, D669*, D699* | Lynch syndrome 1 | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr7:6026730
- GRCh38:
- Chr7:5987099
| PMS2 | E245fs, E299fs, E365fs, E369fs, E385fs, E398fs, E401fs, E421fs, E434fs, E444fs, E448fs, E450fs, E453fs, E490fs, E500fs, E504fs, E520fs, E556fs, E564fs, E618fs | Lynch syndrome 1 | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:48027430
- GRCh38:
- Chr2:47800291
| MSH6 | D770Y, G468C, G595C, G640C, G671C, G714C, G744C, G770C, G772C, G802C | Lynch syndrome 1 | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:47470308-47807597
| BCYRN1, EPCAM, KCNK12, MSH2, MSH2-OT1 | | Lynch syndrome 1 | Pathogenic (Jun 22, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr2:47643536
- GRCh38:
- Chr2:47416397
| MSH2 | Q328H, Q337H, Q348H, Q49H, Q298H, Q208H, Q282H | Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 | Uncertain significance (Oct 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47635594-47635595
- GRCh38:
- Chr2:47408455-47408456
| MSH2 | K90fs, K24fs | Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 | Pathogenic (Feb 7, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:37059085
- GRCh38:
- Chr3:37017594
| MLH1 | Y195*, Y260*, Y293*, Y52* | Lynch syndrome 1, Hereditary nonpolyposis colorectal carcinoma | Likely pathogenic (Oct 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47702211
- GRCh38:
- Chr2:47475072
| MSH2 | D304Y, D463Y, D537Y, D553Y, D151Y, D592Y, D583Y, D603Y, D616Y | Hereditary cancer-predisposing syndrome, Lynch syndrome 1 | Likely pathogenic (Mar 21, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47643444
- GRCh38:
- Chr2:47416305
| MSH2 | E268*, E19*, E318*, E178*, E298*, E307*, E252* | Hereditary cancer-predisposing syndrome, Lynch syndrome 1 | Pathogenic (Dec 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47639638
- GRCh38:
- Chr2:47412499
| MSH2 | L104*, L244*, L178*, L224* | Lynch syndrome 1, Hereditary cancer-predisposing syndrome | Pathogenic (Feb 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:5876369-6122058
| AIMP2, CCZ1, EIF2AK1, OCM, PMS2, RSPH10B | | Lynch syndrome 1 | Pathogenic (Nov 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47657062-47657063
- GRCh38:
- Chr2:47429923-47429924
| MSH2 | A354fs, A420fs | Lynch syndrome 1 | Pathogenic (Oct 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47656941-47656942
- GRCh38:
- Chr2:47429802-47429803
| MSH2 | P319fs, P385fs | Lynch syndrome 1 | Pathogenic (Sep 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47637390
- GRCh38:
- Chr2:47410251
| MSH2 | L109fs, L175fs | Lynch syndrome 1 | Likely pathogenic (Jun 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr7:6029692-6029693
- GRCh38:
- Chr7:5990061-5990062
| PMS2 | | Lynch syndrome 1 | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr2:47656968-47656969
- GRCh38:
- Chr2:47429829-47429830
| MSH2 | | Lynch syndrome 1 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr22:29091768
- GRCh38:
- Chr22:28695780
| CHEK2 | V176fs, V330fs, V440fs, V397fs, V368fs | Lynch syndrome 1 | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:37035130
- GRCh38:
- Chr3:36993639
| MLH1 | A31D | Hereditary cancer-predisposing syndrome | Uncertain significance (Sep 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47613709-47613710
- GRCh38:
- Chr2:47386570-47386571
| EPCAM | | Lynch syndrome 1 | Likely pathogenic (Jun 3, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr11:108099920
- GRCh38:
- Chr11:108229193
| ATM | Y67* | Lynch syndrome 1 | Likely pathogenic (Jul 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:23619220-23619221
- GRCh38:
- Chr16:23607899-23607900
| PALB2 | V1105fs | Lynch syndrome 1 | Likely pathogenic (Nov 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47639611
- GRCh38:
- Chr2:47412472
| MSH2 | K169T, K235T | Hereditary cancer-predisposing syndrome, Lynch syndrome 1 | Uncertain significance (Jul 7, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47690211
- GRCh38:
- Chr2:47463072
| MSH2 | N411fs, N477fs | Lynch syndrome 1 | Pathogenic (Jun 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47705487
- GRCh38:
- Chr2:47478348
| MSH2 | A697P, A763P | Lynch syndrome 1 | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47693796
- GRCh38:
- Chr2:47466657
| MSH2 | | Hereditary cancer-predisposing syndrome, Lynch syndrome 1 | Pathogenic/Likely pathogenic (May 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47703680-47703681
- GRCh38:
- Chr2:47476541-47476542
| MSH2 | E662*, E728* | Lynch syndrome 1 | Likely pathogenic (Jul 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47630444
- GRCh38:
- Chr2:47403305
| MSH2 | D38E | Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 | Conflicting interpretations of pathogenicity (May 5, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47643435
- GRCh38:
- Chr2:47416296
| MSH2 | G249C, G315C | Mismatch repair cancer syndrome 2, Lynch syndrome 1, Muir-Torré syndrome, Hereditary nonpolyposis colorectal neoplasms | Uncertain significance (Mar 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47672691-47672692
- GRCh38:
- Chr2:47445552-47445553
| MSH2 | H362fs, H428fs | Hereditary nonpolyposis colorectal neoplasms | Pathogenic (Jul 11, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47643553
- GRCh38:
- Chr2:47416414
| MSH2 | N288S, N354S | Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1, Hereditary cancer-predisposing syndrome
| Uncertain significance (Aug 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47641532-47641535
- GRCh38:
- Chr2:47414393-47414396
| MSH2 | V241fs, V307fs | Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 | Pathogenic (Jan 11, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48033499
- GRCh38:
- Chr2:47806360
| MSH6 | | Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 | Likely pathogenic (Jul 28, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:37035093-37035101
- GRCh38:
- Chr3:36993602-36993610
| MLH1 | I19fs | Lynch syndrome 1 | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr2:47630479
- GRCh38:
- Chr2:47403340
| MSH2 | A50V | Lynch syndrome 1, Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms
| Conflicting interpretations of pathogenicity (Sep 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47703685-47703692
- GRCh38:
- Chr2:47476546-47476553
| MSH2 | M663fs, M729fs | Lynch syndrome 1 | not provided | no assertion provided |
| - GRCh37:
- Chr3:37086066-37089603
- GRCh38:
- Chr3:37044575-37048112
| MLH1 | | Colorectal cancer, hereditary nonpolyposis, type 2 | Pathogenic (Dec 1, 1996) | no assertion criteria provided |
| - GRCh37:
- Chr2:47610875-47615785
- GRCh38:
- Chr2:47383736-47388646
| EPCAM | | Lynch syndrome 1 | not provided | no assertion provided |
| - GRCh37:
- Chr2:47706634
- GRCh38:
- Chr2:47479495
| MSH2 | | Hereditary cancer-predisposing syndrome | Likely pathogenic (Apr 6, 2022) | criteria provided, single submitter |
| | MSH2 | | Lynch syndrome 1 | Pathogenic (Sep 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47637343-47637344
- GRCh38:
- Chr2:47410204-47410205
| MSH2 | Q160fs, Q94fs | not provided, Lynch syndrome 1 | Pathogenic (Jan 6, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48032171-48032174
- GRCh38:
- Chr2:47805032-47805035
| MSH6 | | Lynch syndrome 1, Hereditary cancer-predisposing syndrome | Uncertain significance (Feb 14, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47702166-47702167
- GRCh38:
- Chr2:47475027-47475028
| MSH2 | Y522fs, Y588fs | Lynch syndrome 1 | Likely pathogenic (Apr 2, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr3:37061918
- GRCh38:
- Chr3:37020427
| MLH1 | L237fs, L302fs, L335fs, L94fs | Lynch syndrome 1, Hereditary cancer-predisposing syndrome | Pathogenic (Apr 2, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47702303
- GRCh38:
- Chr2:47475164
| MSH2 | | Lynch syndrome 1, Hereditary cancer-predisposing syndrome | Conflicting interpretations of pathogenicity (Mar 26, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47698181
- GRCh38:
- Chr2:47471042
| MSH2 | I515fs, I581fs | Lynch syndrome 1, Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome
| Pathogenic/Likely pathogenic (Feb 7, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47705644
- GRCh38:
- Chr2:47478505
| MSH2 | Y749C, Y815C | Hereditary nonpolyposis colorectal neoplasms, not provided, Lynch syndrome 1
| Uncertain significance (Jul 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:37061894-37061896
- GRCh38:
- Chr3:37020403-37020405
| MLH1 | Q230del, Q295del, Q328del, Q87del | Lynch syndrome 1 | Likely pathogenic (Mar 29, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47705566
- GRCh38:
- Chr2:47478427
| MSH2 | L724fs, L790fs | Hereditary cancer-predisposing syndrome, Lynch syndrome 1 | Pathogenic/Likely pathogenic (Jul 6, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47635665
- GRCh38:
- Chr2:47408526
| MSH2 | K113*, K47* | Lynch syndrome 1 | Pathogenic (Sep 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47672686
- GRCh38:
- Chr2:47445547
| MSH2 | | Lynch syndrome 1, Hereditary nonpolyposis colorectal neoplasms | Pathogenic/Likely pathogenic (Jan 11, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47702396
- GRCh38:
- Chr2:47475257
| MSH2 | H665fs, H599fs | Lynch syndrome 1, Hereditary nonpolyposis colorectal neoplasms | Pathogenic (Jan 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:190682764
- GRCh38:
- Chr2:189818038
| PMS1 | R86K, R147K | Lynch syndrome 1 | Uncertain significance (Mar 27, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47630503-47630504
- GRCh38:
- Chr2:47403364-47403365
| MSH2 | K59fs | Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Lynch syndrome 1
| Pathogenic (May 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47702412
- GRCh38:
- Chr2:47475273
| MSH2 | | Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 | Uncertain significance (Sep 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47637504
- GRCh38:
- Chr2:47410365
| MSH2 | L147R, L213R | Lynch syndrome 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47710152
- GRCh38:
- Chr2:47483013
| MSH2 | | Lynch syndrome 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47710135
- GRCh38:
- Chr2:47482996
| MSH2 | | Lynch syndrome 1, not specified | Conflicting interpretations of pathogenicity (Aug 15, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47637428
- GRCh38:
- Chr2:47410289
| MSH2 | E122K, E188K | Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 | Uncertain significance (Dec 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47709894
- GRCh38:
- Chr2:47482755
| MSH2 | | Hereditary cancer-predisposing syndrome, Lynch syndrome 1, Hereditary nonpolyposis colorectal neoplasms
| Pathogenic/Likely pathogenic (Jun 5, 2023) | criteria provided, multiple submitters, no conflicts |
| | MLH1 | | Lynch syndrome 1 | Likely pathogenic | no assertion criteria provided |
| | MLH1 | | Lynch syndrome 1 | Pathogenic | no assertion criteria provided |
| | MLH1 | | Lynch syndrome 1 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:37090036-37090037
- GRCh38:
- Chr3:37048545-37048546
| MLH1 | I285fs, I402fs, I588fs, I545fs, I302fs, I643fs, I610fs | Lynch syndrome 1 | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:37090446
- GRCh38:
- Chr3:37048955
| MLH1 | A583fs, A650fs, A323fs, A440fs, A340fs, A626fs, A648fs, A681fs | Lynch syndrome 1 | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:37061799
- GRCh38:
- Chr3:37020308
| MLH1 | | Lynch syndrome 1 | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:37090485
- GRCh38:
- Chr3:37048994
| MLH1 | E453*, E596*, E661*, E694*, E639*, E336*, E353*, E663* | Hereditary cancer-predisposing syndrome, not provided | Pathogenic (Apr 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:37067225-37067235
- GRCh38:
- Chr3:37025734-37025744
| MLH1 | A282fs, A39fs, A139fs, A22fs, A347fs, A380fs | Lynch syndrome 1 | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:37081734-37081737
- GRCh38:
- Chr3:37040243-37040246
| MLH1 | A506fs, A181fs, A198fs, A298fs, A539fs, A441fs | Lynch syndrome 1 | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:37081730
- GRCh38:
- Chr3:37040239
| MLH1 | W440fs, W197fs, W505fs, W180fs, W297fs, W538fs | Lynch syndrome 1 | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:47606980
- GRCh38:
- Chr2:47379841
| EPCAM | P244A | Lynch syndrome 1 | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr3:37050323
- GRCh38:
- Chr3:37008832
| MLH1 | N60fs, N125fs, N158fs | Hereditary cancer-predisposing syndrome | Pathogenic (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47612354
- GRCh38:
- Chr2:47385215
| EPCAM | | Lynch syndrome 1 | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr2:47643576
- GRCh38:
- Chr2:47416437
| MSH2 | | Lynch syndrome 1 | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr3:37090388-37090402
- GRCh38:
- Chr3:37048897-37048911
| MLH1 | | Lynch syndrome 1 | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:48026625
- GRCh38:
- Chr2:47799486
| MSH6 | H371Q, H501Q, H199Q | Lynch syndrome 1 | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr3:37045930-37045934
- GRCh38:
- Chr3:37004439-37004443
| MLH1 | T18fs, T116fs, T83fs | Lynch syndrome 1 | Likely pathogenic (May 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr3:37035042
- GRCh38:
- Chr3:36993551
| MLH1 | S2A | Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome | Uncertain significance (Jul 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47698130
- GRCh38:
- Chr2:47470991
| MSH2 | Y497C, Y563C | Hereditary nonpolyposis colorectal neoplasms, Muir-Torré syndrome, Lynch syndrome 1, Mismatch repair cancer syndrome 2, Hereditary cancer-predisposing syndrome | Conflicting interpretations of pathogenicity (Aug 10, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47705549
- GRCh38:
- Chr2:47478410
| MSH2 | H719fs, H785fs | Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Lynch syndrome 1
| Pathogenic (May 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47710038-47710040
- GRCh38:
- Chr2:47482899-47482901
| MSH2 | N854del, N920del | Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome | Uncertain significance (Aug 31, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47703565
- GRCh38:
- Chr2:47476426
| MSH2 | A623T, A689T | Hereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 2, Lynch syndrome 1, Muir-Torré syndrome, Hereditary nonpolyposis colorectal neoplasms | Conflicting interpretations of pathogenicity (Mar 20, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:37067319-37067321
- GRCh38:
- Chr3:37025828-37025830
| MLH1 | I378fs, I411fs, I53fs, I313fs, I70fs, I170fs | Hereditary cancer-predisposing syndrome | Pathogenic (Apr 11, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47739658
- GRCh38:
- Chr2:47512519
| KCNK12, MSH2 | | Lynch syndrome 1 | Likely benign (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47739521
- GRCh38:
- Chr2:47512382
| KCNK12, MSH2 | | Lynch syndrome 1 | Uncertain significance (May 28, 2019) | criteria provided, single submitter |